These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

790 related articles for article (PubMed ID: 26450000)

  • 1. The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies.
    Teuteberg JJ; Slaughter MS; Rogers JG; McGee EC; Pagani FD; Gordon R; Rame E; Acker M; Kormos RL; Salerno C; Schleeter TP; Goldstein DJ; Shin J; Starling RC; Wozniak T; Malik AS; Silvestry S; Ewald GA; Jorde UP; Naka Y; Birks E; Najarian KB; Hathaway DR; Aaronson KD;
    JACC Heart Fail; 2015 Oct; 3(10):818-28. PubMed ID: 26450000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial.
    Najjar SS; Slaughter MS; Pagani FD; Starling RC; McGee EC; Eckman P; Tatooles AJ; Moazami N; Kormos RL; Hathaway DR; Najarian KB; Bhat G; Aaronson KD; Boyce SW;
    J Heart Lung Transplant; 2014 Jan; 33(1):23-34. PubMed ID: 24418731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding risk factors and predictors for stroke subtypes in the ENDURANCE trials.
    Cho SM; Starling RC; Teuteberg J; Rogers J; Pagani F; Shah P; Uchino K; Hiivala N
    J Heart Lung Transplant; 2020 Jul; 39(7):639-647. PubMed ID: 32044205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal bleeding in recipients of the HeartWare Ventricular Assist System.
    Goldstein DJ; Aaronson KD; Tatooles AJ; Silvestry SC; Jeevanandam V; Gordon R; Hathaway DR; Najarian KB; Slaughter MS;
    JACC Heart Fail; 2015 Apr; 3(4):303-13. PubMed ID: 25770405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An examination of survival by sex and race in the HeartWare Ventricular Assist Device for the Treatment of Advanced Heart Failure (ADVANCE) Bridge to Transplant (BTT) and continued access protocol trials.
    Birks EJ; McGee EC; Aaronson KD; Boyce S; Cotts WG; Najjar SS; Pagani FD; Hathaway DR; Najarian K; Jacoski MV; Slaughter MS;
    J Heart Lung Transplant; 2015 Jun; 34(6):815-24. PubMed ID: 25813372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drive-line infections and sepsis in patients receiving the HVAD system as a left ventricular assist device.
    John R; Aaronson KD; Pae WE; Acker MA; Hathaway DR; Najarian KB; Slaughter MS;
    J Heart Lung Transplant; 2014 Oct; 33(10):1066-73. PubMed ID: 25087103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in continuous-flow left ventricular assist device therapy as a bridge to transplantation: a risk-adjusted comparison using a propensity score-matching analysis.
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; García Sáez D; Amrani M; Bahrami T; De Robertis F; Wahlers T; Banner NR; Popov AF; Simon AR
    Artif Organs; 2015 Mar; 39(3):212-9. PubMed ID: 25175547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological complications and outcomes in the Berlin Heart EXCOR® pediatric investigational device exemption trial.
    Jordan LC; Ichord RN; Reinhartz O; Humpl T; Pruthi S; Tjossem C; Rosenthal DN
    J Am Heart Assoc; 2015 Jan; 4(1):e001429. PubMed ID: 25613996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term support of patients receiving a left ventricular assist device for advanced heart failure: a follow-up analysis of the Registry to Evaluate the HeartWare Left Ventricular Assist System.
    Schmitto JD; Zimpfer D; Fiane AE; Larbalestier R; Tsui S; Jansz P; Simon A; Schueler S; Strueber M
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):834-838. PubMed ID: 27412342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial clinical experience with the HeartWare left ventricular assist system: a single-center report.
    Dell'Aquila AM; Schneider SR; Schlarb D; Redwan B; Sindermann JR; Ellger B; Stypmann J; Tjan TD; Scheld HH; Hoffmeier A
    Ann Thorac Surg; 2013 Jan; 95(1):170-7. PubMed ID: 23141906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent blood stream infection in patients supported with a continuous-flow left ventricular assist device is associated with an increased risk of cerebrovascular accidents.
    Trachtenberg BH; Cordero-Reyes AM; Aldeiri M; Alvarez P; Bhimaraj A; Ashrith G; Elias B; Suarez EE; Bruckner B; Loebe M; Harris RL; Zhang JY; Torre-Amione G; Estep JD
    J Card Fail; 2015 Feb; 21(2):119-25. PubMed ID: 25463739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentre Canadian experience with the HeartWare ventricular assist device: concerns about adverse neurological outcomes.
    Bashir J; Legare JF; Freed DH; Cheung A; Rao V; Toma M
    Can J Cardiol; 2014 Dec; 30(12):1662-7. PubMed ID: 25475468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombus on the inflow cannula of the HeartWare HVAD: an update.
    Glass CH; Christakis A; Fishbein GA; Watkins JC; Strickland KC; Mitchell RN; Padera RF
    Cardiovasc Pathol; 2019; 38():14-20. PubMed ID: 30399526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes after implantation of a centrifugal flow left ventricular assist device and concurrent cardiac valve procedures.
    Milano C; Pagani FD; Slaughter MS; Pham DT; Hathaway DR; Jacoski MV; Najarian KB; Aaronson KD;
    Circulation; 2014 Sep; 130(11 Suppl 1):S3-11. PubMed ID: 25200052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of device thrombus in the HeartWare HVAD: Success and outcomes depend significantly on the initial treatment strategy.
    Stulak JM; Dunlay SM; Sharma S; Haglund NA; Davis MB; Cowger J; Shah P; Masood F; Aaronson KD; Pagani FD; Maltais S
    J Heart Lung Transplant; 2015 Dec; 34(12):1535-41. PubMed ID: 26681123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.